07/17/2025
4:09 PM | Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2025
2:39 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2025
7:18 AM | Esperion Therapeutics (Issuer)
THOMPSON JOHN CRAIG (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/02/2025
7:21 AM | Esperion Therapeutics (Issuer)
THOMPSON JOHN CRAIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
7:14 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
5:44 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
5:44 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
5:45 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
2:34 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2025
2:16 PM | Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2025
8:01 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ESPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/06/2025
6:25 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
11:15 PM | Esperion Therapeutics (Filer)
| Form EFFECT | |
04/17/2025
3:20 PM | Esperion Therapeutics (Filer)
| Form DEFA14A | |
04/17/2025
3:24 PM | Esperion Therapeutics (Filer)
| Form ARS | |
04/17/2025
2:08 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2025
2:14 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
1:15 PM | Esperion Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
04/04/2025
3:15 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
2:20 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:23 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:11 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
4:15 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:17 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
10:12 AM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/07/2025
8:04 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
6:26 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
2:34 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:26 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
1:37 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
3:37 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:38 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
2:30 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
2:17 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
7:40 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:13 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:14 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
6:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Think you missed gold’s boom? Think again (Ad) If you've been watching gold's historic run and wondering if it's too late… I've got good news.
Because there's a $15 fund tied directly to gold's surge that's still paying massive income…
Up to 64% annually — with payouts every 30 days. Click here to see how to secure the next payout before it's too late. |
12/17/2024
2:46 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:21 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2024
5:43 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:42 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:22 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:33 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:09 AM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:08 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:34 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/17/2024
2:25 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:11 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
2:20 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
2:28 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:33 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2024
3:08 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:21 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
